Theseus Pharmaceuticals Inc. Common Stock (THRX)

Summary
Stock Details

THRX Chart

52-Week Range: N/A
Market Capitalization: N/A
Short Percentage: 0%

Target Price: $10.20
Shares Outstanding: 0
Next Earnings: Nov 30

View More Stats

Catalysts

DateCategoryCatalyst

No upcoming catalysts found

Help your fellow traders

News and Press Releases

We searched over 50 sources and couldn't find any news or press releases related to Theseus Pharmaceuticals Inc. Common Stock.

Here are some articles we think you might like.

Holley Inc. to Release Third Quarter 2021 Results on November 10, 2021
Business Wire | October 25th
HLLY
Wall Street Is Underestimating This Tech Stock
The Motley Fool | October 25th
LTCH
DallasNews Corporation Announces Third Quarter 2021 Financial Results
GlobeNewsWire | October 25th
DALN
Portman Ridge Finance Corporation Schedules Third Quarter 2021 Earnings Release and Conference Call
GlobeNewsWire | October 25th
PTMN
With Fisker, Believe It When You See It
InvestorPlace | October 25th
FSR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of InnovAge Holding Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 13, 2021 - INNV
Newsfile Corp | October 25th
INNV
FaZe Clan SPAC Merger: 9 Things for RILY and BRPM Stock Investors to Know About the $1B Deal
InvestorPlace | October 25th
BRPM
INNV Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Innovage Holding Corp. Shareholders of Class Action and Encourages Investors to Contact the Firm
Business Wire | October 25th
INNV
Grocery Manufacturers, Retailers Predict Sales Growth Amid Rising Costs and Supply Chain Challenges, Advantage Sales Reports
GlobeNewsWire | October 25th
ADV
SES to Announce World's Largest Li-Metal Battery and Giga Facility at Battery World
Business Wire | October 25th
IVAN
Outbrain Partners with Grupo Abril, Reinforcing Leadership in Recommendation Market
GlobeNewsWire | October 25th
OB
Sharecare's Dr. Nirav R. Shah named to Advisory Committee to CDC Director
PRNewsWire | October 25th
SHCR
Here's What Could Drive Growth for Unity Software in the Future
The Motley Fool | October 25th
U
Bright HealthCare Expands Affordable Health Plan Options and Care Delivery Network in North Carolina
Business Wire | October 25th
BHG
Evolv Technology Partnership Enables Pittsburgh Cultural Trust to Welcome Guests Back With Enhanced Security and Seamless Experience
Business Wire | October 25th
EVLV

Company Info

Website: N/A
Address: N/A
Sector: Other
Industry: Other
Full time employees: 13

Stock Details

Current Price: $16.02
52-Week Low: N/A
52-Week High: N/A
Most Recent Quarter: 0000-00-00

Shares Float: 0
Shares Outstanding: 0
Market Capitalization: N/A
Next Earnings Date: 0000-00-00

Short Interest

Shares Short
(Today): 0
Short Ratio: 0.00

Shares Short
(Last Month): 0
Short Interest: 0.00%

The short interest for Theseus Pharmaceuticals Inc. Common Stock is at 0.00%, which is low amongst its peers.

Stock Ownership

Retail: 100.00%

Insiders: 0.00%

Instutitions: 0.00%

Analyst Target Price

10.20

Theseus Pharmaceuticals Inc. Common Stock is currently $10.20 below Wallstreet Analysts' price target.

Yesterday's Volume

N/A

Discussions

Please log in or register to share your thoughts.

tighttechniq10/11/21 11:51pm

$THRX this market love evrry dips let’s see

0 Like Report